Guidance on use of unlicensed medicines for children

May 11, 2009 by admin 

New guidelines aimed at minimising the ‘potential pitfalls’ linked with the unlicensed prescribing of medicines for children and improve understanding of the clinical, ethical and legal issues has been written by a group of academics and practitioners, and sponsored by Rosemont Pharmaceuticals Ltd. (See Making medicines safer for children- guidance for the use of unlicensed medicines in paediatric patients). It includes advice on issues such as the primary/secondary care interface, considerations for different classes of unlicensed medicines, and the importance of complete information.

Filed under: Latest News for Nurse Prescribers
Tagged: ,

Comments

Comments are closed.